Mar. 16 at 3:51 PM
$SLS These are the Days to Be Loading in as many as you can Nut Sack Up.
--- How long is too long to wait for 40x Returns?
Most of the inch thick mile wide tools on this board, think tomorrow is --- but Smart Long, Institutional Fund Analysts Live for these Massive Near Term Catalysts.
- Could be ANY Day Now Here.
Gps worth
$40B Plus the Instant the GPs Phase 3 Registrational Results are announced - and we are conceivably in the ANY DAY NOW Zone.
SLS Valuation:
• GPs 12,500 AML CR2/3 Patients Each Year
• GPs 40,000 AML CR1 Patients Each Year
+ 100,000 AML Patients Currently in Remission who'll Immediately benefit from and be Eligible for Gps
• xCCo Estimated
$280K Revenue Per Patient Year 1
• Ad-Infinite Multi-year Dosing Regime Compounds Rev.
•
$110K Per Patient Year 2 Revenue.
• Gps WT1+ PR/ROC
$IMGN $ABBV $10.1B BO Comp
• 1M WT1+ patients Diagnosed Globally each year
• SLS009 AML-MR Direct Comp
$GILD $4.9B BO.
rNPV for CR2/3 - this is the TAM - just for CR2/3
